Overview

Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether memantine delays the progression of driving impairment in patients with mild Alzheimer's Disease (AD).
Phase:
Phase 4
Details
Lead Sponsor:
Florida Atlantic University
Collaborator:
Forest Laboratories
Treatments:
Memantine